Affinity Capital Advisors, LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1810023
BERKELEY, CA
Position in ESPR
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$31,600
+$31,600 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#25
of 40 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Affinity Capital Advisors, LLC holds $31,600 across 1 Drug Manufacturers - Specialty & Generic name. ESPR ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESPR |
Esperion Therapeutics, Inc.
This page
|
10,000 | $31,600 |
All Filings in ESPR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,600 | 10,000 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | — | 10,000 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | — | 10,000 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | — | 10,000 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | — | 10,000 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | — | 10,000 | Shares | Sole | 2025-04-17 | |
| No filing history on record for this holder in this stock. | ||||||